Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
CLNN
Strong SellSinkerClene Inc. · Consumer Defensive · United States · $54M · Avg Vol: $340K/d
COMPANY DESCRIPTION
Clene Inc. is a clinical-stage biopharmaceutical company pioneering the development of clean-surfaced nanocrystal (CSN) therapeutics for neurodegenerative diseases. The company's competitive advantage lies in its proprietary nanotechnology platform, which produces CNM-Au8, a gold nanocrystal suspension designed to enhance cellular energy and protect neurons in diseases like ALS and Multiple Sclerosis. Clene operates as a highly specialized biotech innovator, utilizing a novel therapeutic mechanism to address progressive neurological decline.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.5M | 0.7M | 0.3M | 0.2M | -24.9% | 0.2M | 0.2M | — | 24.7% |
| EPS | -2.69 | -9.43 | -5.67 | -2.65 | — | -3.55 | -2.62 | -2.44 | — |
| Shares | 12.8M | 6.4M | 8.1M | 10.8M | -15.1% | 12.8M | — | — | — |
| Debt | 31.8M | 32.2M | 20.8M | 21.7M | -12.0% | 22.3M | — | — | — |
| Equity | 3.2M | 13.4M | -8.9M | -17.6M | 313.7% | — | — | — | — |
| Op CF | -39.0M | -30.2M | -21.3M | -18.5M | — | -15.9M | — | — | — |
| Inv CF | -10.2M | -1.5M | 6.3M | -39.0K | — | — | — | — | — |
| Fin CF | 17.2M | 42.2M | -1.5M | 11.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of CLNN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CLNN | Clene Inc.(you) | $54M | 0 | Strong Sell |
| BOF | BranchOut Food Inc. | $64M | 5 | Strong Sell |
| DDC | DDC Enterprise Limited | $63M | 10 | Strong Sell |
| BRID | Bridgford Foods Corporation | $56M | 14 | Strong Sell |
| NPRA.CN | Nepra Foods Inc. | $43M | 14 | Strong Sell |
| BYND | Beyond Meat, Inc. | $238M | 4 | Strong Sell |
| BRCC | BRC Inc. | $120M | 20 | Sell |
| HAIN | The Hain Celestial Group, Inc. | $66M | 33 | Sell |
| FTLF | FitLife Brands, Inc. | $92M | 29 | Sell |
| ENHA | Enhanced Group Inc. | $628M | 2 | Strong Sell |
Peer medians: ROE 10.0% · P/E 20.4x · Gross margin 34.5%